Printer Friendly
The Free Library
18,914,768 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Eisai Announces Results of Overseas Clinical Trials of Donepezil in Treating Vascular Dementia.


Tokyo, Japan, Mar 17, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Eisai announced the results of its latest clinical trials of donepezil in patients with vascular dementia vascular dementia
n.
A steplike deterioration in intellectual functions that result from multiple infarctions of the cerebral hemispheres. Also called multi-infarct dementia.
 (VaD) on March 16.

Randomized ran·dom·ize  
tr.v. ran·dom·ized, ran·dom·iz·ing, ran·dom·iz·es
To make random in arrangement, especially in order to control the variables in an experiment.
, double-blinded tests were conducted in nine countries with patients with VaD and with no prior diagnosis of Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. . Compared with a placebo group, the subjects receiving donepezil showed significant improvement in cognitive functions but not in global functions.

No statistically significant difference in the occurrence of adverse effects was observed. However, the mortality rate was higher in the donepezil group than the placebo one.

In the US, Japan and the EU, donepezil, under the trade name Aricept, is currently indicated for the treatment of mild to moderate Alzheimer's disease but not for VaD. In the meantime Adv. 1. in the meantime - during the intervening time; "meanwhile I will not think about the problem"; "meantime he was attentive to his other interests"; "in the meantime the police were notified"
meantime, meanwhile
, it is available for the treatment of VaD in India, New Zealand, the Philippines, Romania, South Korea and Thailand.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Mar 17, 2006
Words:153
Previous Article:Kobayashi Pharmaceutical Introduces New OTC Anemia Treatment.
Next Article:Consumer Finance Companies Set Self-Imposed Limits on TV Advertising.



Related Articles
Help and Hope for Alzheimer's Patients and Their Loved Ones.
IMMUNE NETWORK HALTS PHASE I INTERACTION TRIAL.
Canadian Consensus Conference on Dementia, February 27-28, 1998: Conference Highlights [*].
Highlights From the Annual Scientific Assembly: Managing the Stages of Alzheimer's Disease--new management options. (Special Feature).
Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia. (Case Report).
Treatments for Alzheimer disease.(Review Article)
Eisai Files Application Seeking Additional Indication for ARICEPT in US.
Eisai Files Application Seeking Additional Indication for ARICEPT in Europe.
Eisai Recieves Positive Opinion for Inovelon(R) Marketing Authorization from European Committee for Medicinal Products for Human Use (CHMP).
Eisai Announces Inovelon(R) Receives Marketing Authorization Approval from European Commission.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles